Trials / Completed
CompletedNCT00401674
MITO-5: Weekly Carboplatin and Paclitaxel as First Line Chemotherapy for Elderly Patients With Ovarian Cancer
Phase II Multicenter Study of the Combination of Weekly Carboplatin and Paclitaxel as First-line Chemotherapy for Elderly Patients With Ovarian Cancer.
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 26 (actual)
- Sponsor
- National Cancer Institute, Naples · Academic / Other
- Sex
- Female
- Age
- 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the toxicity and activity of weekly administration of carboplatin and paclitaxel as first-line chemotherapy for elderly patients with ovarian cancer stage IC-IV.
Detailed description
This is a phase II multicenter study. The experimental treatment is carboplatin (AUC 2) and paclitaxel 60 mg/m2, on days 1, 8 and 15 every 28 days.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | carboplatin | |
| DRUG | paclitaxel |
Timeline
- Start date
- 2003-06-01
- Primary completion
- 2008-06-01
- Completion
- 2008-06-01
- First posted
- 2006-11-20
- Last updated
- 2016-01-14
Locations
10 sites across 1 country: Italy
Source: ClinicalTrials.gov record NCT00401674. Inclusion in this directory is not an endorsement.